Related Experiment Videos
Radiotherapy and combined modality approaches in localised prostate cancer
1The Institute of Cancer Research and The Royal Marsden NHS Trust, Academic Unit of Radiotherapy, Sutton, Surrey, UK.
European Journal of Cancer (Oxford, England : 1990)
|March 13, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer.
Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT).
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2019
Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity.
Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer.
Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.
European journal of cancer (Oxford, England : 1990)·2026
Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.
European journal of cancer (Oxford, England : 1990)·2026
Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.
European journal of cancer (Oxford, England : 1990)·2026
Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.
European journal of cancer (Oxford, England : 1990)·2026
Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.
European journal of cancer (Oxford, England : 1990)·2026
Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.
European journal of cancer (Oxford, England : 1990)·2026
A Monte Carlo based dose verification tool for an HDR Ir-192 brachytherapy source and its evaluation on extremity malignancies.
Journal of applied clinical medical physics·2026
Pulmonary ventilation images from planning CT images using deep learning on locally-advanced NSCLC patients.
Journal of applied clinical medical physics·2026
Herpetic reactivation during radiotherapy treatment for gynaecological cancers-a retrospective observational study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Radiodynamic Therapy Using Local Administration of 5-Aminolevulinic Acid for In Vivo Osteosarcoma Xenograft Model.
In vivo (Athens, Greece)·2026